Palés J, Palacios-Araus L, López A, Gual A
Laboratori de Neurofisiologia i Biomembranes, Unitat de Fisiologia Humana--Facultat de Medicina, Universitat de Barcelona, Spain.
Biochim Biophys Acta. 1991 May 7;1064(2):169-74. doi: 10.1016/0005-2736(91)90298-m.
[Ca2+]i increase is necessary in physiological platelet activity, particularly aggregation and release. The increase of [Ca2+]i observed during platelet activation depends in part on Ca2+ influx from the extracellular medium. The participation of voltage-operated Ca2+ channels as a pathway for Ca2+ entry is controversial. In the present study we have attempted to reinvestigate this problem by measuring aggregation and [Ca2+]i changes in platelets activated by ADP or thrombin and incubated with organic or inorganic blockers of calcium channels. The main findings of the present paper can be summarized as follows: (i) Ni2+, Co2+ and Mn2+, well known inorganic blockers of Ca2+ channels, inhibited platelet aggregation induced by ADP or thrombin in a dose-dependent manner, Ni2+ being the most effective agent. (ii) Thrombin induced a rise in free [Ca2+]i in platelets incubated both in 1 mmol/l Ca(2+)-containing medium and in nominally Ca(2+)-free medium; the rise of free [Ca2+]i was in the first case up to 370 +/- 31 nmol/l and in the second case up to 242 +/- 26 nmol/l, indicating that this observed difference was due to Ca2+ entry from the extracellular medium. Co2+ and Ni2+ abolished that difference by inhibiting Ca2+ influx. (iii) Nisoldipine, nitrendipine and nimodipine (10-50 nmol/l) inhibited in a dose-dependent manner platelet aggregation induced by either ADP or thrombin in platelets incubated in normal-Ca2+ normal-K+ medium, also, aggregation was inhibited to a similar extent in platelets incubated in normal-Ca2+ high-K+ medium. (iv) Nisoldipine--the most effective dihydropyridine to inhibit platelet aggregation--also inhibited Ca2+ influx in platelets incubated in normal-Ca2+ medium, either in normal-K+ or high-K+ media. Our data support the existence of voltage-operated, dihydropyridine-sensitive calcium channels (L-type) and a physiological role for them in platelet function.
细胞内钙离子浓度([Ca2+]i)升高在生理性血小板活性中是必需的,尤其是在聚集和释放过程中。血小板激活过程中观察到的[Ca2+]i升高部分取决于细胞外介质中钙离子的内流。电压门控性钙离子通道作为钙离子进入途径的参与情况存在争议。在本研究中,我们试图通过测量由ADP或凝血酶激活并与钙离子通道的有机或无机阻滞剂一起孵育的血小板中的聚集和[Ca2+]i变化来重新研究这个问题。本文的主要发现可总结如下:(i)镍离子(Ni2+)、钴离子(Co2+)和锰离子(Mn2+)是众所周知的钙离子通道无机阻滞剂,它们以剂量依赖性方式抑制ADP或凝血酶诱导的血小板聚集,其中Ni2+是最有效的药物。(ii)凝血酶在含1 mmol/L钙离子的培养基和名义上无钙离子的培养基中孵育的血小板中均诱导游离[Ca2+]i升高;在第一种情况下,游离[Ca2+]i升高至370±31 nmol/L,在第二种情况下升高至242±26 nmol/L,表明观察到的这种差异是由于钙离子从细胞外介质进入所致。Co2+和Ni2+通过抑制钙离子内流消除了这种差异。(iii)尼索地平、尼群地平和尼莫地平(10 - 50 nmol/L)以剂量依赖性方式抑制在正常钙离子 - 正常钾离子培养基中孵育的血小板中由ADP或凝血酶诱导的血小板聚集,同样,在正常钙离子 - 高钾离子培养基中孵育的血小板中聚集也受到类似程度的抑制。(iv)尼索地平——抑制血小板聚集最有效的二氢吡啶类药物——也抑制在正常钙离子培养基中孵育的血小板中的钙离子内流,无论是在正常钾离子还是高钾离子培养基中。我们的数据支持电压门控性、对二氢吡啶敏感的钙离子通道(L型)的存在及其在血小板功能中的生理作用。